SEKISUI Diagnostics
Emily Wang is an Associate Analytical Scientist at SEKISUI Diagnostics, a position held since October 2023. Prior experience includes serving as a Protein Scientist at FabricNano from April 2022 to October 2023 and completing a PhD at the University of Liverpool from October 2017 to April 2022, focusing on the Shank3 protein's role in dendritic spine regulation. Additional roles include a placement student at Ipsen and an industrial placement at MedImmune, where experience was gained in antibody characterization and in vivo behavioral studies, respectively. Emily’s earlier experience includes an industrial trainee role at Pfizer and various positions at Boots UK, including dispenser and healthcare assistant, which involved significant community interaction and support in pharmacy services. Educational qualifications include a Bachelor's Degree in Neuroscience from the University of Manchester and A levels from HSDC Alton.
This person is not in the org chart
This person is not in any offices
SEKISUI Diagnostics
4 followers
Headquartered in Burlington, MA, for 40 years SEKISUI Diagnostics has been committed to helping improve the lives of patients by providing innovative medical diagnostics to physicians and laboratories. We continue to invest in the areas of diabetes, infectious disease, coagulation, diagnostic enzymes and automated systems, and have a leading position as a provider of rapid tests in the US and high throughput coagulation systems in Japan. Our workforce spans six sites located in four countries. We are a sister company to SEKISUI Medical in Japan, making us a worldwide company with R&D and Manufacturing facilities on three continents. We develop, manufacture, and supply billions of tests each year to the global healthcare market through our commercial networks and partners. Our product lines include: • Clinical chemistry reagents • Coagulation reagents • Point-of-care rapid tests and immunoassay system • Enzymes and specialty biochemicals